NCT04132336View on ClinicalTrials.gov

Study to Find Out the Optimal Dose of Caffeine in the Combination Tablet of Naproxen Sodium and Caffeine in Patients Experiencing Moderate to Severe Pain After Having Wisdom Teeth Removed

PHASE2CompletedINTERVENTIONAL
Enrollment

193

Participants

Timeline

Start Date

November 12, 2019

Primary Completion Date

March 2, 2020

Study Completion Date

March 3, 2020

Conditions
Pain, Postoperative
Interventions
DRUG

Naproxen sodium/Caffeine (BAY2880376)

Tablet, oral, single dose

DRUG

Naproxen sodium (Aleve)

Tablet, oral, single dose

DRUG

Caffeine

Tablet, oral, single dose

DRUG

Placebo

Tablet, oral, single dose

Trial Locations (1)

84107

JBR Clinical Research, Salt Lake City

Sponsors

Lead Sponsor

Bayer
All Listed Sponsors
lead

Bayer

INDUSTRY

NCT04132336 - Study to Find Out the Optimal Dose of Caffeine in the Combination Tablet of Naproxen Sodium and Caffeine in Patients Experiencing Moderate to Severe Pain After Having Wisdom Teeth Removed | Biotech Hunter | Biotech Hunter